Sedation and Acute Encephalopathy in a Pediatric Patient Following Ingestion of Delta-8-Tetrahydrocannabinol Gummies

11 November 2021: Articles

Unusual clinical course, Management of emergency care, Clinical situation which can not be reproduced for ethical reasons

Peter Akpunonu ^A* , Regan A. Baum ^A , Andrew Reckers ^A , Blake Davidson ^A , Ross Ellison ^A , Matthew Riley ^A , Jordan Trecki ^A , Roy Gerona ^A

DOI: 10.12659/AJCR.933488

Am J Case Rep 2021; 22:e933488

Table 1. Laboratory results.

Samples Analyzed for the Drug Enforcement Administration by the UCSF Clinical Toxicology and Environmental Biomonitoring Laboratory (liquid chromatography – quadrupole time-of-flight mass spectrometer)
Sample	Confirmed drug	Concentration (ng/ml)
Serum	Delta-8-THC	107.6
Serum	11-nor-9-carboxy-delta-8-THC	746.5
Urine	11-nor-9-carboxy-delta-8-THC	1550